Necessity of Aspiration in the Ventrogluteal Site

Ege University834 enrolled

Overview

H1: Aspiration is not necessary for IM injections applied from the ventrogluteal region. H2: Aspiration procedure increases pain in IM injections applied from ventrogluteal region. H3: The duration of the aspiration procedure on IM injections applied from the ventrogluteal region is effective on pain.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

834

Conditions

Nursing Injection Site

Interventions

The Necessity of AspirationOTHER

The patients who met the inclusion criteria and agreed to participate in the study were assigned to the Experimental Group A who were administered IM injection during which aspiration lasted for 5-10 seconds, to the Control Group who were administered IM injection during which aspiration lasted for 1-2 seconds, and to the Experimental Group B who were not administered IM injection according to the stratified block randomization list. The same "Intramuscular Injection Application Protocol" was applied while all the injections were administered.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patient who came to the Emergency Service Care Unit for "Diclofenac Sodium" injection * Have no vision and hearing problems, * Who have no disease that may affect their perception of pain * Who can evaluate the "Visual Analog Scale" correctly, scoring 5 points or less from the VAS, * Body Mass Index is between 18.5-24.9 kg / m2, * Who do not have any discomfort in the extremities that will prevent them from taking the desired position, * No complications due to intramuscular injections such as abscess, infection, tissue necrosis and hematoma in the ventrogluteal region * No nodules or masses in the area Exclusion Criteria: * Patients who refuse the injection are excluded.

Locations (1)

Ege University Hospital

Izmir, Turkey (Türkiye)

Outcomes

Primary Outcomes

Individual Introductory Information Form

The content of the study was explained to the patients coming to the emergency room. Written informed consents were obtained in line with the "Individual Introductory Information Form" of the patients. Individual Introductory Information Form: This form includes questions such as the patient's application group, diagnosis, age, gender, height, weight, and blood intake during aspiration in intramuscular injection. It is completed within the first 10-15 minutes of contact with the patient.

Time frame: 15 minutes

Visual Analog Scale (VAS)

Intramuscular injection was performed in accordance with the application group assigned to the patients who filled the Individual Introductory Information Form. The patients were not told which group they belonged to. A nurse who except the researcher who performed the application evaluated pain levels that patients feel during injection immediately after the intramuscular injection application, with a Visual Analog Scale. The minimum score that can be obtained from this scale is 0 and the maximum score is 10. A higher score indicates that the pain is more severe. This scale was applied in minutes 1-5 after intramuscular injection.

Time frame: 5 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.